Islam et al., "Vasopressin neurons in the paraventricular hypothalamus promote wakefulness via lateral hypothalamic orexin neurons," Curr
A new generation of oral tablets, multi-target agonists, and next-generation injectables is reshaping the competitive landscape at pace, with fresh regulatory approvals, pivotal Phase 3 data, and an expanding list of indications that stretches far beyond weight loss and type 2 diabetes
Health and Human Services, who himself is advocating peptides, stem cells, and other interventions for which data are lacking
Current evidence does not establish a direct causal link between semaglutide and clinically significant liver damage in most patients
Written by gozerian Hear it First: Join our Mailing List Sign up to receive new product updates, exclusive discounts, news, and more!